ButlerAS,BehrmanRE,,2007,,Preterm birth: causes,,-
RushRW,DaveyDA,SegallML,,1978,The effect of preterm delivery on perinatal mortality,Br J Obstet Gynaecol,85,806-11
NelsonDB,McIntireDD,McDonaldJ,GardJ,TurrichiP,LevenoKJ,,2017,-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study,Am J Obstet Gynecol,216,e600-1
O'Brien,JM , Adair,CD , Lewis,DF , Hall,DR , Defranco,EA , Fusey,S,,2007,Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial,Ultrasound Obstet Gynecol,30,687-96
BittarER,YamasakiAA,SasakiS,ZugaibM.,,1996,Cervical fetal fibronectina in patients at increased risk for preterm delivery,Am J Obstet Gynecol,175,178-81
CunninghamFG,GantNF,LevenoKJ,GilstrapIII LC,HauthJC,WenstromKD,Prentice-Hall International,,1997,Preterm and postterm pregnancy and fetal growth retardation,,,797-826
ErnyR,PigneA,ProuvostC,GamerreM,MaletC,SermentH,,1986,The effects of oral administration of progesterone for premature labor,Am J Obstet Gynecol,154,525-9
CheckJH,LeeG,EpsteinR,VetterB,,1992,Increased rate of preterm deliveries in untreated women with luteal phase deficiencies,Gynecol Obstet Invest,33,183-4
LockwoodCJ,SenyeiAE,DischieMR,CasalD,ShahKD,ThugSN,,1991,Fetal fibronectina in cervical and vaginal secretions as a predictor of preterm delivery,N Engl J Med,325,669-74
MichalA,Elovitz , MD,ConjecvarmM.,,2006,The use of progestational agents for preterm birth: lessons from a mouse model,Am J Obstet Gynecol,195,1004-10
,2017,The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth,Am J Obstet Gynecol,216,B11-3
RomeroR,YeoL,MirandaJ,HassanSS,Conde-AgudeloA,ChaiworapongsaT.,,2013,A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix,J Perinat Med,41,27-44
PanethNS,,1995,The problem of low birth weight,Future Child,5,19-34
MattisonDR,DamusK,FioreE,PetriniJ,AlterC,,2001,Preterm delivery: a public health perspective,Paediatr Perinat Epidemiol,15,7-16
CreasyRK,,1993,Preterm birth prevention: where are we?,Am J Obstet Gynecol,168,1223-30
JohnsonJW,AustinKL,JonesGS,DavisGH,KingTM,,1975,Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor,N Engl J Med,293,675-80
HauthJC,GilstrapLC,BrekkenAL,HauthJM,,1983,The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population,Am J Obstet Gynecol,146,187-90
HobelCJ,RossMG,BemisRL,BragonierJR,NessimS,SandhuM,,1994,Program impact on high-risk women,Am J Obstet Gynecol,170,54-62
FuchsF,StakemannG,,1960,Treatment of threatened premature labor with large doses of progesterone,Am J Obstet Gynecol,79,172-6
FuchsAR,FuchsF,,1984,Endocrinology of human parturition: a review,Br J Obstet Gynaecol,91,948-67
,2003,American college of obstetricians and gynaecologists. ACOG committee opinion: use of progesterone to reduce preterm birth,Obstet Gynecol,102,1115-6
RittenbergC,NewmanRB,IstwanNB,RheaDJ,StanzianoGJ,,2009,Preterm birth prevention by 17 alphahydroxyprogesteronecaproate vs,Daily Nursing Surveillance. J Reprod Med,54,47-52